Insmed Inc (INSM) Earning Prediction
Insmed Inc (INSM) is set to release its earnings performance on 02/19 07:00:00 ET in Pre-Market trading. Consensus forecasts predict a revenue of 263.87M and an earnings per share (EPS) of -1.07 for the . With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!
Earnings Surprise Analysis
INSM Transcript
The earnings call summary and Q&A section indicate positive sentiment overall. Strong financial metrics and optimistic guidance, especially regarding BRINSUPRI and ARIKAYCE, suggest potential stock price growth. The strategic plan highlights multiple upcoming catalysts, including new drug launches and trials. Management's confidence in market access and revenue opportunities further supports a positive outlook. However, some concerns remain about physician prescribing depth and market access clarity. Despite these, the overall tone is optimistic, warranting a positive sentiment rating.
INSM Slides
Insmed Q4 2025 slides reveal strong BRINSUPRI launch, projects 139% revenue growth for 2026Insmed Q3 2025 slides reveal strong BRINSUPRI debut, ARIKAYCE growth acceleratesInsmed Q2 2025 slides reveal 19% revenue growth amid clinical pipeline advancesInsmed Q1 2025 slides: ARIKAYCE sales surge 23% as brensocatib launch approachesINSM Report
Frequently Asked Questions
What is the Insmed Inc {quarter} Earnings Release Date and Time?
Insmed Inc (INSM) is scheduled to release its {quarter} earnings report on Feb 19, 2026, Pre-Market (approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.
What Are the Consensus Forecasts for Insmed Inc {quarter} Revenue and EPS?
Analysts' consensus predicts 263.87M in revenue and an EPS of -1.07 for Insmed Inc's {quarter}.
What Does Intellectia's AI Predict for Insmed Inc {quarter} Earnings?
Intellectia's exclusive AI algorithms forecast a {conclusion} for Insmed Inc's {quarter} earnings, with a prediction date of Feb 19, 2026. Insmed Inc {summary}
How Can I Use This Earnings Prediction to Trade INSM Stock?
Leverage Intellectia's AI forecast to position trades ahead of the Feb 19, 2026 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.
How Accurate Is Intellectia's AI for Earnings Predictions Like Insmed Inc {quarter}?
Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.
How does AI Earnings Prediction generate its forecasts?
AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!
When are the predictions available, and how often are they updated?
Predictions are generated two days before a company's earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They're updated in real-time if significant news breaks, ensuring you get fresh insights.
Can I use AI Earnings Prediction for all types of stocks?
Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2025-2026 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!
